中文
Earlier issues
Announcement
More
Progress in Chemistry 2018, Vol. 30 Issue (10): 1573-1583 DOI: 10.7536/PC180742 Previous Articles   Next Articles

• Review •

Application Prospect of Metal Complexes in Chemoimmunotherapy of Tumors

Yuewen Sun1, Suxing Jin1, Xiaoyong Wang1*, Zijian Guo2   

  1. 1. State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China;
    2. State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China
  • Received: Revised: Online: Published:
  • Supported by:
    The work was supported by the National Natural Science Foundation of China(No. 31570809).
PDF ( 837 ) Cited
Export

EndNote

Ris

BibTeX

Tumor chemoimmunotherapy is a new method for the treatment of tumors through the combination of immunotherapy and chemotherapy taking advantage of synergistic effect. Metal drugs, represented by platinum agents, are important chemotherapeutic antitumor drugs with cross-linking DNA and preventing DNA replication as the mechanism of action. Nevertheless, these drugs have severe general toxicity and drug resistance. In recent years it was found that in addition to producing cytotoxicity, some metal complexes are involved in the immunomodulation by various mechanisms, including the most common induction of immunogenic cell death (ICD). This review introduces the basic concepts of tumor chemoimmunotherapy and the tumor microenvironment related to immunosuppression, outlines the immune activities and basic principles for immunomodulation of metal complexes like those of platinum. Finally, some non-platinum metal complexes with ICD-inducing potentials and other immunomodulating functions are described, and the existing problems and application potential of chemoimmunotherapy in the future are indicated. The combination of chemotherapy and immunotherapy not only makes use of the human immune system to enhance the antitumor effect of metal complexes, but also reduces the dose and toxic side effects of drugs, and therefore is one of the new directions for the design of metal-based antitumor drugs.
Contents
1 Introduction
1.1 Tumor immunotherapy and chemotherapy
1.2 Immunosuppressive tumor microenvironment
2 Metal complexes and chemoimmunotherapy
2.1 Immunocompetence of metal complexes
2.2 Immunomodulation effect of metal complexes
2.3 Immunogenic cell death
3 Chemoimmunotherapeutic effect of platinum-based drugs
3.1 Potential pathways for platinum-based drugs participating in immunomodulation
3.2 Platinum complexes with ICD-inducing effect
3.3 Chemoimmunotherapeutic platinum complexes
3.4 Combination of platinum-based drugs with other drugs for chemoimmunotherapy
4 Immunostimulation potential of non-platinum complexes
5 Conclusion and outlook
Key words: metal complex, platinum antitumor drug, chemoimmunotherapy, inorganic medicinal chemistry, chemical biology

CLC Number: 

[1] June C H. J. Clin. Invest., 2007, 117:1466.
[2] Pardoll D M. Nat. Rev. Cancer., 2012, 12:252.
[3] Liao W, Lin J X, Leonard W J. Immunity., 2013, 38:13.
[4] Ramakrishnan R, Gabrilovich D I. Cancer Immunol. Immunother., 2013, 62:405.
[5] Klemm F, Joyce J A. Trends Cell Biol., 2015, 25:198.
[6] Swartz M A, Iida N, Roberts E W, Sangaletti S, Wong M H, Yull F E, Coussens L M, DeClerck Y A. Cancer Res., 2012, 72:2473.
[7] Verhoeven D, Stoppelenburg A J, Meyer-Wentrup F, Boes M. Clin. Immunol., 2018, 190:22.
[8] Dunn G P, Bruce A T, Ikeda H, Old L J, Schreiber R D. Nat. Immunol., 2002, 3:991.
[9] Munn D H, Bronte V. Curr. Opin. Immunol., 2016, 39:1.
[10] Khong H T, Restifo N P. Nat. Immunol., 2002, 3:999.
[11] Wherry E J. Nat. Immunol., 2011, 12:492.
[12] Chen L P, Flies D B. Nat. Rev. Immunol., 2013, 13:227.
[13] Keir M E, Butte M J, Freeman G J, Sharpe A H. Annu. Rev. Immunol., 2008, 26:677.
[14] Gabrilovich D I, Nagaraj S. Nat. Rev. Immunol., 2009, 9:162.
[15] Wood K J, Sakaguchi S. Nat. Rev. Immunol., 2003, 3:199.
[16] Roncarolo M G, Battaglia M. Nat. Rev. Immunol., 2007, 7:585.
[17] Rosenberg B. Cancer Chemother Rep. 1975, 59:589.
[18] Chang C L, Hsu Y T, Wu C C, Lai Y Z, Wang C N, Yang Y C, Wu T C, Hung C F. Cancer Res., 2013, 73:119.
[19] Taniguchi K, Nishiura H, Yamamoto T. J. Immunother., 2011, 34:480.
[20] Liu Q L, Wang Y F, Wang H, Liu Y Y, Liu T, Kunda P E. Cancer Res. Clin. Oncol., 2013, 139:1357.
[21] Sukkurwala A Q, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco E E, Galluzzi L, Zitvogel L, Kepp O. OncoImmunology., 2014, 3:e28473.
[22] Mattarollo S R, Loi S, Duret H, Ma Y T, Zitvogel L, Smyth M J. Cancer Res., 2011, 71:4809.
[23] Lake R A, Robinson B W S. Nat. Rev. Cancer., 2005, 5:397.
[24] Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. Nat. Rev. Drug Discov., 2012, 11:215.
[25] Ramakrishnan R, Huang C, Cho H I, Lloyd M, Johnson J, Ren X, Altiok S, Sullivan D, Weber J, Celis E, Gabrilovich D I. Cancer Res., 2012, 72:5483.
[26] Rnhjizvi N A, Hellmann M D, Brahmer J R, Juergens R A, Borghaei H, Gettinger S, Chow L Q, Gerber D E, Laurie S A, Goldman J W, Shepherd F A, Shen Y, Nathan F E, Harbison C T, Antonia S. J. Clin. Oncol., 2016, 34:2969.
[27] Obeid M, Tesniere A, Ghiringhelli F, Fimia G M, Apetoh L, Perfettini J L, Castedo M, Mignot G, Panaretakis T, Casares N. Nat. Med., 2007, 13:54.
[28] Rad A N, Pollara G, Sohaib S M A, Chiang C, Chain B M, Katz D R. Cancer Res., 2003, 63:5143.
[29] Tseng C W, Hung C F, Alvarez R D, Trimble C, Huh W K, Kim D, Chuang C M, Lin C T, Tsai Y C, He L M, Monie A, Wu T C. Clin. Cancer Res., 2008, 14:3185.
[30] Sharma A, Ramanjaneyulu A, Ray R, Rajeswari M R. DNA Cell Biol., 2009, 28:311
[31] Green D R, Ferguson T, Zitvogel L, Kroemer G. Nat. Rev. Immunol., 2009, 9:353.
[32] Kepp O, Tesniere A, Zitvogel L, Kroemer G. Curr. Opin. Oncol., 2009, 21:71.
[33] 张峻岭(Zhang J L), 李卫泊(Li W B), 李冬斌(Li D B), 谢绍建(Xie S J), 蔡建辉(Cai J H). 免疫学杂志(Immunological Journal), 2010, 26(08):730.
[34] Vacchelli E, Senovilla L, Eggermont A, Fridman W H, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Oncoimmunology., 2013, 2:e23510.
[35] Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira J P, Delaloge S, Kroemer G, Zitvoge L. Immunol. Rev., 2007, 220:47.
[36] Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri M C, Ullrich E, Saulnier, P. Nat. Med. 2007, 13:1050.
[37] Krysko D V, Garg A D, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Nat. Rev. Cancer., 2012, 12:860.
[38] Garg A D, Krysko D V, Verfaillie T, Kaczmarek A, Ferreira G B, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek A J M. EMBO J., 2012, 31:1062.
[39] Chao M P, Jaiswal S, Weissman-Tsukamoto R, Alizadeh A A, Gentles A J, Volkmer J, Weiskopf K, Willingham S B, Raveh T, Park C Y. Sci. Transl. Med., 2010, 2:63ra94.
[40] Tesniere A, Schlemmer F, Boige V, Kepp O, Martins I, Ghiringhelli F, Aymeric L, Michaud M, Apetoh L, Barault L. Oncogene., 2010, 29:482.
[41] Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Curr. Opin. Immunol., 2008, 20:504.
[42] Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala A Q, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L. Cytokine Growth Factor Rev., 2013, 24:311.
[43] Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G. Cancer Cell., 2015, 28:690.
[44] Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Annu. Rev. Immunol., 2013, 31:51.
[45] Pol J, Vacchelli E, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautes-Fridman C, Fucikova J, Galon J, Spisek R. Oncoimmunology., 2015, 4:e1008866.
[46] Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spisek R. Cancer Res., 2011, 71:4821.
[47] Wang X Y, Guo Z J. Chem. Soc. Rev., 2013, 42:202.
[48] Wang D, Lippard S J. Nat. Rev. Drug Discov., 2005, 4:307.
[49] Curtis F A, Reed P, Wilson L A, Bowers L Y, Yeo R P, Sanderson, J M, Walmsley A R, Sharples G J. J. Mol. Recognit., 2011, 24:333.
[50] Lichtenstein A K, Pende D. Cancer Res., 1986, 46:639.
[51] Ramakrishnan R, Assudani D, Nagaraj S, Hunter T, Cho H I, Antonia S, Altiok S, Celis E, Gabrilovich D I. J. Clin. Invest., 2010, 120:1111.
[52] Chen G, Emens L A. Cancer Immunol. Immunother., 2013, 62:203.
[53] Nowak A K, Lake R A, Marzo A L, Scott B, Heath W R, Collins E J, Frelinger J A, Robinson B W S. J. Immunol., 2003, 170:4905.
[54] Shurin G V, Tourkova I L, Kaneno R, Shurin M R. J. Immunol., 2009, 183:137.
[55] Zitvogel L, Galluzzi L, Smyth M J, Kroemer, G. Immunity, 2013, 39:74.
[56] Terenzi A, Pirker C, Keppler B K, Berger W. J. Inorg. Biochem., 2016, 165:71.
[57] Jungwirth U, Xanthos D N, Gojo J, Bytzek A K, Korner W, Heffeter P, Abramkin S A, Jakupec M A, Hartinger C G, Windberger U. Mol. Pharmacol., 2012, 81:719.
[58] Abramkin S A, Jungwirth U, Valiahdi S M, Dworak C, Habala L, Meelich K, Berger W, Jakupec M A, Hartinger C G, Nazarov A A. J. Med. Chem., 2010, 53:7356.
[59] Wong D Y Q, Ong W W F, Ang W H. Angew. Chem. Int. Ed., 2015, 54:6483.
[60] Fanelli M, Formica M, Fusi V, Giorgi L, Micheloni M, Paoli P. Coord. Chem. Rev., 2016, 310:41.
[61] Dilruba S, Kalayda G V. Cancer Chemother. Pharmacol., 2016, 77:1103.
[62] Arsenijevic M, Milovanovic M, Jovanovic S, Arsenijevic N, Markovic B S, Gazdic M, Volarevic V. J. Biol. Inorg. Chem., 2017, 22:807.
[63] Huang J, Chen K, Chen J, Gong W, Dunlop N M, Howard O M Z, Gao Y, Bian X W, Wang J M. Br. J. Cancer., 2010, 102:1052.
[64] Zhou Y, Bian X W, Le Y Y, Gong W H, Hu J Y, Zhang X, Wang L H, Iribarren P, Salcedo R, Howard O M Z. JNCI-J. Natl. Cancer Inst., 2005, 97:823.
[65] Kim S D, Lee H Y, Shim J W, Kim H J, Baek S H, Zabel B A, Bae Y S. PLoS One, 2012, 7:e30522.
[66] Wong D Y Q, Yeo C H F, Ang W H. Angew. Chem.-Int. Edit., 2014, 53:6752.
[67] Lo Re D, Montagner D, Tolan D; Di Sanza C, Iglesias M, Calon A, Giralt E. Chem Commun., DOI:10.1039/c8cc02071j
[68] Davar D, Bahary N. Target. Oncol., 2018, 13, 125.
[69] Muller A J, DuHadaway J B, Donover P S, Sutanto-Ward E, Prendergast G C. Nat. Med., 2005, 11:312.
[70] Awuah S G, Zheng Y R, Bruno P M, Hemann M T, Lippard S J. J. Am. Chem. Soc., 2015, 137:14854.
[71] Pfirschke C, Engblom C, Rickelt S, Cortez-Retamozo V, Garris C, Pucci F, Yamazaki T, Poirier-Colame V, Newton A, Redouane Y. Immunity., 2016, 44:343.
[72] Wang N, Wang Z G, Xu Z F, Chen X F, Zhu G Y. Angew. Chem. Int. Edit., 2018, 57:3426.
[73] Krishnamachari Y, Geary S M, Lemke C D, Salem A K. Pharm. Res., 2011, 28:215.
[74] Huang M H, Huang C Y, Lin S C, Chen J H, Ku C C, Chou A H, Liu S J, Chen H W, Chong P, Leng C H. Microbes Infect., 2009, 11:654.
[75] Ghoneum M, Ghoneum A, Gimzewski J. Anticancer Res., 2010, 30:4075.
[76] Meng X J, Leyva M L, Jenny M, Gross I, Benosman S, Fricker B, Harlepp S, Hébraud P, Boos A, Wlosik P, Bischoff P, Sirlin C, Pfeffer M, Loeffler J P, Gaiddon C. Cancer Res., 2009, 69:5458.
[77] Cao R, Jia J L, Ma X C, Zhou M, Fei H. J. Med. Chem., 2013, 56:3636.
[78] Suntharalingam K, Johnstone T C, Bruno P M, Lin W, Hemann M T, Lippard S J. J. Am. Chem. Soc., 2013, 135:14060.
[79] Bortolozzi R, Viola G, Porcù E, Consolaro F, Marzano C, Pellei M, Gandin V, Basso G. Oncotarget., 2014, 5:5978.
[80] Tardito S, Bassanetti I, Bignardi C, Elviri L, Tegoni M, Mucchino C, Bussolati O, Franchi-Gazzola R, Marchiò L. J. Am. Chem. Soc., 2011, 133:6235.
[81] Gandin V, Tisato F, Dolmella A, Pellei M, Santini C, Giorgetti M, Marzano C, Porchia M. J. Med. Chem., 2014, 57:4745.
[82] Jaouen G, Vessières A, Top S. Chem. Soc. Rev., 2015, 44:8802.
[83] Arambula J F, McCall R, Sidoran K J, Magda D, Mitchell N A, Bielawski C W, Lynch V M, Sessler J L, Arumugam K. Chem. Sci. 2016, 7:1245.
[84] Shalapour S, Font-Burgada J, Di Caro G, Zhong Z Y, Sanchez-Lopez E, Dhar D, Willimsky G, Ammirante M, Strasner A, Hansel D E. Nature, 2015, 521:94.
[85] Lesterhuis W J, Punt C J A, Hato S V, Eleveld-Trancikova D, Jansen B J H, Nierkens S, Schreibelt G, de Boer A, Van Herpen C M L, Kaanders J H. J. Clin. Invest., 2011, 121:3100.
[1] Gaojie Yan, Qiong Wu, Linghua Tan. Design, Synthesis and Applications of Nitrogen-Rich Azole-Based Energetic Metal Complexes [J]. Progress in Chemistry, 2021, 33(4): 689-712.
[2] Wendi Guo, Ye Liu. Carbonylation of Alkynes with Different Nucleophiles Catalyzed By Transition Metal Complexes [J]. Progress in Chemistry, 2021, 33(4): 512-523.
[3] Jiaen Xie, Yuheng Luo, Qianling Zhang, Pingyu Zhang. Metal Complexes in Application of Two-Photon Luminescence Probes [J]. Progress in Chemistry, 2021, 33(1): 111-123.
[4] Zehuai Mou, Yinjun Wang, Hongyan Xie. Rare-Earth Metal Complexes-Mediated Stereoselective Polymerization of Aromatic Polar Vinyl Monomers [J]. Progress in Chemistry, 2020, 32(12): 1885-1894.
[5] Huina Zou, Shoufei Zhu. Progresses of 1,10-Phenanthroline Type Ligands in Fe/Co/Ni Catalysis [J]. Progress in Chemistry, 2020, 32(11): 1766-1803.
[6] Shiying Yang, Yichao Xue, Manqian Wang. Complexed Heavy Metal Wastewater Treatment: Decomplexation Mechanisms Based on Advanced Oxidation Processes [J]. Progress in Chemistry, 2019, 31(8): 1187-1198.
[7] Zhonggao Zhou, Yangyang Yuan, Guohai Xu, Zhengwang Chen, Mei Li. The Synthesis and Catalytic Activity of Sugar-Based NHCs and Their Transition Metal Complexes [J]. Progress in Chemistry, 2019, 31(2/3): 351-367.
[8] Kangqiang Qiu, Hongyi Zhu, Liangnian Ji, Hui Chao. Real-Time Luminescence Tracking in Living Cells with Metal Complexes [J]. Progress in Chemistry, 2018, 30(10): 1524-1533.
[9] Zhan Peng, Wang Xueshun, Liu Xinyong. Contemporary Molecular Targeted Drug in the Context of “Precision Medicine”: An Attempting Discussion of “Precision Drug Design” [J]. Progress in Chemistry, 2016, 28(9): 1363-1386.
[10] Deng Yunpan, Yang Bo, Yu Gang, Zhuo Qiongfang, Deng Shubo, Zhang Hong. Catalytic Hydrodehalogenation of Halogenated Organic Compounds with Metal Complexes [J]. Progress in Chemistry, 2016, 28(4): 564-576.
[11] Liu Xin, Wu Chuan, Wu Feng, Bai Ying. Light Metal Complex Hydride Hydrogen Storage Systems [J]. Progress in Chemistry, 2015, 27(9): 1167-1181.
[12] Chen Feng, Bai Ying, Li Jiayun*, Xiao Wenjun, Peng Jiajian*. The Application on Nitrogen-Coordinating Transition Metal Complexes on Hydrosilylation [J]. Progress in Chemistry, 2015, 27(7): 806-817.
[13] Wang Jiamin, Shi Lei, Liu Haiyang. The Interaction of Corrole and Its Metal Complex with DNA and Their Anti-Tumor Activity [J]. Progress in Chemistry, 2015, 27(6): 755-762.
[14] Wang Xue, Tan Chen, Li Yongqi, Zhang Heng, Liu Ye. Synthesis of Ionic Phosphines and Corresponding Ionic Transition Metal Complexes and Their Applications in Homogeneous Catalysis [J]. Progress in Chemistry, 2015, 27(1): 27-37.
[15] Liu Yuping, Xie Jian, Li Tingting, Deng Ling, Chen Changguo, Zhang Dingfei. Development of Mg-Transition Metal Complex as Cathode Materials [J]. Progress in Chemistry, 2014, 26(09): 1596-1608.